We are live on ! Find out more
VVM

Versant Venture Management Portfolio holdings

AUM $141M
1-Year Est. Return 190.82%
This Fund
S&P 500
This Quarter Est. Return
-17.01%
1 Year Est. Return
+190.82%
3 Year Est. Return
+375.7%
5 Year Est. Return
+81.85%
10 Year Est. Return
+4,735.29%
AUM
$174M
AUM Growth
+$95.5M
Cap. Flow
+$139M
Cap. Flow %
79.75%
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$94.5M
2
OCUL icon
Ocular Therapeutix
OCUL
+$44.5M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 93.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GKOS icon
1
Glaukos
GKOS
$8.89B
$76M 43.59%
+3,142,217
New +$94.5M
CLVS
2
DELISTED
Clovis Oncology, Inc.
CLVS
$37.5M 21.49%
407,416
– –
OCUL icon
3
Ocular Therapeutix
OCUL
$1.85B
$31.1M 17.86%
+2,215,384
New +$44.5M
FPRX
4
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$16.8M 9.64%
1,092,152
– –
AKAO
5
DELISTED
Achaogen Inc
AKAO
$7.38M 4.23%
1,281,152
– –
BITI
6
DELISTED
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
$3.52M 2.02%
268,672
– –
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
$2.03M 1.17%
1,048,601
– –

Similar funds

POIA
Pin Oak Investment Advisors Houston, Texas $141M AUM 20.83% 1-Year Est. Return
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return
TM
TFJ Management Somerville, Massachusetts $141M AUM 9.28% 1-Year Est. Return
IA
IF Advisors San Antonio, Texas $141M AUM
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
RB
Renasant Bank Tupelo, Mississippi $141M AUM 16.9% 1-Year Est. Return
YEPX
Yorktown Energy Partners XI New York $142M AUM 130.51% 1-Year Est. Return
CFGW
Chancellor Financial Group WB Wilkes-Barre, Pennsylvania $141M AUM 23.22% 1-Year Est. Return

Versant Venture Management's Q3 2015 Portfolio in Review

As of Q3 2015, Versant Venture Management held 7 positions worth $174M, up 121% from $78.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Versant Venture Management deployed $139M of net new capital in Q3 2015, opening 2 new positions. Its largest new stake was Glaukos: 3,142,217 shares worth $76M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 83% a quarter earlier.

  • Versant Venture Management's largest Q3 2015 buy was Glaukos: 3,142,217 shares worth $76M.
  • Versant Venture Management's ten largest holdings make up 100% of its $174M portfolio in Q3 2015.
  • Versant Venture Management opened 2 new positions and closed 0 in Q3 2015.
  • Versant Venture Management's portfolio value rose 121% quarter-over-quarter to $174M.

Based on Versant Venture Management's 13F filing for Q3 2015, filed 28 Oct 2015.